Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human CDNF ELISA Kit (AC3786)
Cat.#: ASET-2375
Specifications
Description Human CDNF ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human CDNF concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.052 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.5-24 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1502 Mouse Apelin ELISA Kit (AC2913) Quantitative inquiry ASET-2029 Bovine LIF ELISA Kit (AC3440) Quantitative inquiry ASET-1351 Mouse Myelin Basic Protein ELISA Kit (AC2762) Quantitative inquiry ASET-2464 Human CRY2 ELISA Kit (AC3875) Quantitative inquiry ASET-2161 Mouse Niemann Pick C1 ELISA Kit (AC3572) Quantitative inquiry ASET-1756 Rat HEXA ELISA Kit (AC3167) Quantitative inquiry ASET-2539 Human Somatostatin Receptor 5 ELISA Kit (AC3950) Quantitative inquiry ASET-1538 Rat FOXO1A ELISA Kit (AC2949) Quantitative inquiry ASET-1229 Rat Calretinin ELISA Kit (AC2640) Quantitative inquiry ASET-2436 Human LCA10 ELISA Kit (AC3847) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket